OGN 250516 5.00P(OGN250516P5000) Stock Price Today

0.05
0.000.00%

15min DelayClose May 9 16:00 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Minerva2

May 7 03:07

$Organon & Co (OGN.US)$ I will start to buy the dip at 8.00. and add more by every 0.50 drop.

103237380

May 5 21:34

$Organon & Co (OGN.US)$ Top up time?

thedioyears

May 5 17:54

buy the dip?

$Organon & Co (OGN.US)$
Did not expect the dividend cut based on the comments provided on the last CC. Refresher "were committed to regular dividend as the number one capital allocation priority."
I'm glad Umer Raffat from Evercore ISI was able to straight up ask "how can we trust you?"
I understood their logic and managed to buy the "dip". You know what that means...
Lets see what Vtama can do.
As they said in the call, "The Vtama launch performance has been encouraging. As it c...

Minerva2

May 4 00:58

$Organon & Co (OGN.US)$ bought 100 shares at 9.30. buy more if goes down. i do not understand 87million dollar quarterly net income for a 2.5Billion market capital deserve a dump just because dividend goes from 0.28 to 0.02.

Teddy123

Apr 1 19:55

Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.

$Organon & Co (OGN.US)$ $Biogen (BIIB.US)$
Organon Claims US Market Leadership with Groundbreaking Tocilizumab Biosimilar Deal

Market Insights

$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More